Pediatrix Medical Group (MD) Price & Analysis

Compare

241 Followers

MD Stock Chart & Stats

Day’s Range― - ―

52-Week Range$11.40 - $17.67

Previous CloseN/A

Volume66.51K

Average Volume (3M)770.94K

Market Cap

$1.41B

Enterprise Value$1.53B

Total Cash (Recent Filing)$348.33M

Total Debt (Recent Filing)$649.56M

Price to Earnings (P/E)12.6

Beta0.30

Next Earnings

Oct 30, 2025

EPS Estimate

0.47

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.53

Shares Outstanding87,084,190

10 Day Avg. Volume711,828

30 Day Avg. Volume770,936

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap1.08

Enterprise Value/Revenue0.79

Enterprise Value/Gross Profit3.28

Enterprise Value/Ebitda7.51

Forecast

1Y Price Target

$16.75

Price Target Upside0.00%

Rating ConsensusHold

Number of Analyst Covering4

Bulls Say, Bears Say

Bulls Say

Earnings GuidanceThe company raised its 2025 EBITDA guidance, indicating potential for upside despite maintaining a conservative outlook for the second half of the year.

Financial PerformanceStrong quarter driven by solid revenue growth, with volume and pricing contributing significantly.

Stock BuybacksMD is benefiting from a favorable cash balance and a team signaling a desire to increase buybacks, making the company's stock more intriguing.

Bears Say

Subsidy UncertaintyUncertainty remains regarding the sustainability of pricing given the subsidy cliff in 2026.

Trend SustainabilityAnalyst remains reasonably cautious on the sustainability of these trends and incremental improvement.

Pediatrix Medical Group News

Pediatrix Medical Group Announces Share Repurchase Program

The latest announcement is out from Pediatrix Medical Group ( ($MD) ). On August 18, 2025, Pediatrix Medical...

1M ago

Pediatrix Medical announces $250M share repurchase program

Pediatrix Medical (MD) Group announced that its Board of Directors has authorized a share repurchase program of up...

1M ago

Pediatrix Medical price target raised to $16.50 from $16 at UBS

UBS analyst AJ Rice raised the firm’s price target on Pediatrix Medical (MD) to $16.50 from $16 and...

2M ago

Pediatrix Medical sees FY25 adjusted EBITDA $245M-$255M

06:15 EDT Pediatrix Medical (MD) sees FY25 adjusted EBITDA $245M-$255M Published first on TheFly – the ultimate source...

2M ago

Pediatrix Medical reports Q2 adjusted EPS 53c, consensus 42c

Reports Q2 revenue $469M, consensus $464.37M. “Our second quarter operating results exceeded our forecast and reflect continuing strong...

2M ago

Pediatrix Medical Group, Inc. (MD) Q2 Earnings Cheat Sheet

Pediatrix Medical Group, Inc. (MD) is scheduled to report 2nd quarter earnings on 08/05/2025, before the market opens....

2M ago

Cautious Optimism: Evaluating Pediatrix Medical Group Amid Shifting Birth Trends

Analyst Whit Mayo from Leerink Partners maintained a Hold rating on Pediatrix Medical Group and keeping the price...

3M ago

Pediatrix Medical Group Appoints Dr. Kurt Newman to Board

The latest update is out from Pediatrix Medical Group ( ($MD) ). On July 1, 2025, Pediatrix Medical...

3M ago

Cautious Outlook on Pediatrix Medical Group Amid Slowing Birth Trends and Payer Mix Dynamics

In a report released on June 5, Whit Mayo from Leerink Partners maintained a Hold rating on Pediatrix...

4M ago

Pediatrix Medical price target lowered to $16 from $18.50 at UBS

UBS analyst AJ Rice lowered the firm’s price target on Pediatrix Medical (MD) to $16 from $18.50 and...

5M ago

Pediatrix Medical Group Holds Annual Shareholders’ Meeting

An update from Pediatrix Medical Group ( ($MD) ) is now available. On May 8, 2025, Pediatrix Medical...

5M ago

Hold Rating on Pediatrix Medical Group Amid Uncertain Birth Trends and Payer Mix Shifts

Whit Mayo, an analyst from Leerink Partners, maintained the Hold rating on Pediatrix Medical Group (MD – Research...

5M ago

Pediatrix Medical Group Reports Strong Q1 Earnings

Pediatrix Medical Group, Inc. ( ($MD) ) has released its Q1 earnings. Here is a breakdown of the...

5M ago

Pediatrix Medical Group’s Optimistic Q1 Earnings Call

Pediatrix Medical Group, Inc. (($MD)) has held its Q1 earnings call. Read on for the main highlights of...

5M ago

MD FAQ

What was Pediatrix Medical Group’s price range in the past 12 months?

Pediatrix Medical Group lowest stock price was $11.39 and its highest was $17.67 in the past 12 months.

What is Pediatrix Medical Group’s market cap?

Pediatrix Medical Group’s market cap is $1.41B.

When is Pediatrix Medical Group’s upcoming earnings report date?

Pediatrix Medical Group’s upcoming earnings report date is Oct 30, 2025 which is in 29 days.

How were Pediatrix Medical Group’s earnings last quarter?

Pediatrix Medical Group released its earnings results on Jun 30, 2025. The company reported $0.53 earnings per share for the quarter, beating the consensus estimate of $0.425 by $0.105.

Is Pediatrix Medical Group overvalued?

According to Wall Street analysts Pediatrix Medical Group’s price is currently same. Get more investment ideas with TipRanks Premium

Does Pediatrix Medical Group pay dividends?

Pediatrix Medical Group does not currently pay dividends.

What is Pediatrix Medical Group’s EPS estimate?

Pediatrix Medical Group’s EPS estimate is 0.47.

How many shares outstanding does Pediatrix Medical Group have?

Pediatrix Medical Group has 87,084,190 shares outstanding.

What happened to Pediatrix Medical Group’s price movement after its last earnings report?

Pediatrix Medical Group reported an EPS of $0.53 in its last earnings report, beating expectations of $0.425. Following the earnings report the stock price went up 2.281%.

Which hedge fund is a major shareholder of Pediatrix Medical Group?

Currently, no hedge funds are holding shares in MD

Pediatrix Medical Group Stock Smart Score

Neutral

Fundamentals

Return on Equity

14.27%

Trailing 12-Months

Asset Growth

5.35%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Pediatrix Medical Group

Pediatrix Medical Group (MD) is a leading provider of specialized healthcare services for infants, children, and adolescents across the United States. The company operates within the pediatric healthcare sector, focusing on neonatology, pediatric cardiology, and other subspecialties. Pediatrix Medical Group offers a range of services including hospital-based care, outpatient services, and telehealth solutions to ensure comprehensive care for its young patients and their families.

Pediatrix Medical Group (MD) Earnings & Revenues

Historic Earnings Reports

MD Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call highlighted strong financial performance with significant growth in EBITDA, cash flow, and NICU volumes, as well as successful cost management and portfolio restructuring. However, challenges include revenue decline in non-same unit activities and potential headwinds from new legislation. The company remains optimistic about managing these challenges.View all MD earnings summaries

MD Stock 12 Month Forecast

Average Price Target

$16.75

▲(0.00% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"$9","18":"$18","11.25":"$11.25","13.5":"$13.5","15.75":"$15.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$17.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$16.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$16.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,11.25,13.5,15.75,18],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.88,16.889230769230767,16.898461538461536,16.907692307692308,16.916923076923077,16.926153846153845,16.935384615384613,16.944615384615386,16.953846153846154,16.963076923076922,16.97230769230769,16.981538461538463,16.99076923076923,{"y":17,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.88,16.869999999999997,16.86,16.849999999999998,16.84,16.83,16.82,16.81,16.8,16.79,16.78,16.77,16.76,{"y":16.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,16.88,16.85076923076923,16.82153846153846,16.79230769230769,16.763076923076923,16.73384615384615,16.704615384615384,16.675384615384615,16.646153846153847,16.616923076923076,16.587692307692308,16.55846153846154,16.529230769230768,{"y":16.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":10.86,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.21,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.01,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.12,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.98,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.77,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.51,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.74,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.54,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.33,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.98,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.88,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >